img

Global Cyclopentolate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cyclopentolate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Cyclopentolate is a muscarinic antagonist. It is commonly used as an eye drop during pediatric eye examinations to dilate the eye (mydriatic) and prevent the eye from focusing or accommodating (cycloplegic). Cyclopentolate or atropine can also be administered to reverse muscarinic and central nervous system effects of indirect cholinomimetic (anti-AChase) administration.
Cyclopentolate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cyclopentolate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Mydriatic Agent and Muscarinic Receptor Antagonist are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cyclopentolate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cyclopentolate key manufacturers include Alcon, Novartis, Laboratório Edol, Cadila Healthcare, FDC, Dr. Gerhard Mann, Abdi Ibrahim, Laboratorios Sophia and Bausch and Lomb, etc. Alcon, Novartis, Laboratório Edol are top 3 players and held % sales share in total in 2022.
Cyclopentolate can be divided into Patent and Generic, etc. Patent is the mainstream product in the market, accounting for % sales share globally in 2022.
Cyclopentolate is widely used in various fields, such as Mydriatic Agent and Muscarinic Receptor Antagonist, etc. Mydriatic Agent provides greatest supports to the Cyclopentolate industry development. In 2022, global % sales of Cyclopentolate went into Mydriatic Agent filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cyclopentolate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Alcon
Novartis
Laboratório Edol
Cadila Healthcare
FDC
Dr. Gerhard Mann
Abdi Ibrahim
Laboratorios Sophia
Bausch and Lomb
Santen
Riemser Arzneimittel
Teva
Akorn
Segment by Type
Patent
Generic

Segment by Application


Mydriatic Agent
Muscarinic Receptor Antagonist

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cyclopentolate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cyclopentolate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cyclopentolate industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Cyclopentolate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cyclopentolate introduction, etc. Cyclopentolate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Cyclopentolate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Cyclopentolate Market Overview
1.1 Cyclopentolate Product Overview
1.2 Cyclopentolate Market Segment by Type
1.2.1 Patent
1.2.2 Generic
1.3 Global Cyclopentolate Market Size by Type
1.3.1 Global Cyclopentolate Market Size Overview by Type (2024-2034)
1.3.2 Global Cyclopentolate Historic Market Size Review by Type (2024-2024)
1.3.3 Global Cyclopentolate Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cyclopentolate Sales Breakdown by Type (2024-2024)
1.4.2 Europe Cyclopentolate Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Cyclopentolate Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Cyclopentolate Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Cyclopentolate Sales Breakdown by Type (2024-2024)
2 Global Cyclopentolate Market Competition by Company
2.1 Global Top Players by Cyclopentolate Sales (2024-2024)
2.2 Global Top Players by Cyclopentolate Revenue (2024-2024)
2.3 Global Top Players by Cyclopentolate Price (2024-2024)
2.4 Global Top Manufacturers Cyclopentolate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cyclopentolate Market Competitive Situation and Trends
2.5.1 Cyclopentolate Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Cyclopentolate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cyclopentolate as of 2022)
2.7 Date of Key Manufacturers Enter into Cyclopentolate Market
2.8 Key Manufacturers Cyclopentolate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cyclopentolate Status and Outlook by Region
3.1 Global Cyclopentolate Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Cyclopentolate Historic Market Size by Region
3.2.1 Global Cyclopentolate Sales in Volume by Region (2024-2024)
3.2.2 Global Cyclopentolate Sales in Value by Region (2024-2024)
3.2.3 Global Cyclopentolate Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Cyclopentolate Forecasted Market Size by Region
3.3.1 Global Cyclopentolate Sales in Volume by Region (2024-2034)
3.3.2 Global Cyclopentolate Sales in Value by Region (2024-2034)
3.3.3 Global Cyclopentolate Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Cyclopentolate by Application
4.1 Cyclopentolate Market Segment by Application
4.1.1 Mydriatic Agent
4.1.2 Muscarinic Receptor Antagonist
4.2 Global Cyclopentolate Market Size by Application
4.2.1 Global Cyclopentolate Market Size Overview by Application (2024-2034)
4.2.2 Global Cyclopentolate Historic Market Size Review by Application (2024-2024)
4.2.3 Global Cyclopentolate Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cyclopentolate Sales Breakdown by Application (2024-2024)
4.3.2 Europe Cyclopentolate Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Cyclopentolate Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Cyclopentolate Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Cyclopentolate Sales Breakdown by Application (2024-2024)
5 North America Cyclopentolate by Country
5.1 North America Cyclopentolate Historic Market Size by Country
5.1.1 North America Cyclopentolate Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Cyclopentolate Sales in Volume by Country (2024-2024)
5.1.3 North America Cyclopentolate Sales in Value by Country (2024-2024)
5.2 North America Cyclopentolate Forecasted Market Size by Country
5.2.1 North America Cyclopentolate Sales in Volume by Country (2024-2034)
5.2.2 North America Cyclopentolate Sales in Value by Country (2024-2034)
6 Europe Cyclopentolate by Country
6.1 Europe Cyclopentolate Historic Market Size by Country
6.1.1 Europe Cyclopentolate Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Cyclopentolate Sales in Volume by Country (2024-2024)
6.1.3 Europe Cyclopentolate Sales in Value by Country (2024-2024)
6.2 Europe Cyclopentolate Forecasted Market Size by Country
6.2.1 Europe Cyclopentolate Sales in Volume by Country (2024-2034)
6.2.2 Europe Cyclopentolate Sales in Value by Country (2024-2034)
7 Asia-Pacific Cyclopentolate by Region
7.1 Asia-Pacific Cyclopentolate Historic Market Size by Region
7.1.1 Asia-Pacific Cyclopentolate Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Cyclopentolate Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Cyclopentolate Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Cyclopentolate Forecasted Market Size by Region
7.2.1 Asia-Pacific Cyclopentolate Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Cyclopentolate Sales in Value by Region (2024-2034)
8 Latin America Cyclopentolate by Country
8.1 Latin America Cyclopentolate Historic Market Size by Country
8.1.1 Latin America Cyclopentolate Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Cyclopentolate Sales in Volume by Country (2024-2024)
8.1.3 Latin America Cyclopentolate Sales in Value by Country (2024-2024)
8.2 Latin America Cyclopentolate Forecasted Market Size by Country
8.2.1 Latin America Cyclopentolate Sales in Volume by Country (2024-2034)
8.2.2 Latin America Cyclopentolate Sales in Value by Country (2024-2034)
9 Middle East and Africa Cyclopentolate by Country
9.1 Middle East and Africa Cyclopentolate Historic Market Size by Country
9.1.1 Middle East and Africa Cyclopentolate Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Cyclopentolate Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Cyclopentolate Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Cyclopentolate Forecasted Market Size by Country
9.2.1 Middle East and Africa Cyclopentolate Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Cyclopentolate Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Alcon
10.1.1 Alcon Company Information
10.1.2 Alcon Introduction and Business Overview
10.1.3 Alcon Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Alcon Cyclopentolate Products Offered
10.1.5 Alcon Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Novartis Cyclopentolate Products Offered
10.2.5 Novartis Recent Development
10.3 Laboratório Edol
10.3.1 Laboratório Edol Company Information
10.3.2 Laboratório Edol Introduction and Business Overview
10.3.3 Laboratório Edol Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Laboratório Edol Cyclopentolate Products Offered
10.3.5 Laboratório Edol Recent Development
10.4 Cadila Healthcare
10.4.1 Cadila Healthcare Company Information
10.4.2 Cadila Healthcare Introduction and Business Overview
10.4.3 Cadila Healthcare Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Cadila Healthcare Cyclopentolate Products Offered
10.4.5 Cadila Healthcare Recent Development
10.5 FDC
10.5.1 FDC Company Information
10.5.2 FDC Introduction and Business Overview
10.5.3 FDC Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.5.4 FDC Cyclopentolate Products Offered
10.5.5 FDC Recent Development
10.6 Dr. Gerhard Mann
10.6.1 Dr. Gerhard Mann Company Information
10.6.2 Dr. Gerhard Mann Introduction and Business Overview
10.6.3 Dr. Gerhard Mann Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Dr. Gerhard Mann Cyclopentolate Products Offered
10.6.5 Dr. Gerhard Mann Recent Development
10.7 Abdi Ibrahim
10.7.1 Abdi Ibrahim Company Information
10.7.2 Abdi Ibrahim Introduction and Business Overview
10.7.3 Abdi Ibrahim Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Abdi Ibrahim Cyclopentolate Products Offered
10.7.5 Abdi Ibrahim Recent Development
10.8 Laboratorios Sophia
10.8.1 Laboratorios Sophia Company Information
10.8.2 Laboratorios Sophia Introduction and Business Overview
10.8.3 Laboratorios Sophia Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Laboratorios Sophia Cyclopentolate Products Offered
10.8.5 Laboratorios Sophia Recent Development
10.9 Bausch and Lomb
10.9.1 Bausch and Lomb Company Information
10.9.2 Bausch and Lomb Introduction and Business Overview
10.9.3 Bausch and Lomb Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Bausch and Lomb Cyclopentolate Products Offered
10.9.5 Bausch and Lomb Recent Development
10.10 Santen
10.10.1 Santen Company Information
10.10.2 Santen Introduction and Business Overview
10.10.3 Santen Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Santen Cyclopentolate Products Offered
10.10.5 Santen Recent Development
10.11 Riemser Arzneimittel
10.11.1 Riemser Arzneimittel Company Information
10.11.2 Riemser Arzneimittel Introduction and Business Overview
10.11.3 Riemser Arzneimittel Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Riemser Arzneimittel Cyclopentolate Products Offered
10.11.5 Riemser Arzneimittel Recent Development
10.12 Teva
10.12.1 Teva Company Information
10.12.2 Teva Introduction and Business Overview
10.12.3 Teva Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Teva Cyclopentolate Products Offered
10.12.5 Teva Recent Development
10.13 Akorn
10.13.1 Akorn Company Information
10.13.2 Akorn Introduction and Business Overview
10.13.3 Akorn Cyclopentolate Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Akorn Cyclopentolate Products Offered
10.13.5 Akorn Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cyclopentolate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cyclopentolate Industrial Chain Analysis
11.4 Cyclopentolate Market Dynamics
11.4.1 Cyclopentolate Industry Trends
11.4.2 Cyclopentolate Market Drivers
11.4.3 Cyclopentolate Market Challenges
11.4.4 Cyclopentolate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cyclopentolate Distributors
12.3 Cyclopentolate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Patent
Table 2. Major Company of Generic
Table 3. Global Cyclopentolate Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Cyclopentolate Sales by Type (2024-2024) & (K Units)
Table 5. Global Cyclopentolate Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Cyclopentolate Sales by Type (2024-2024) & (US& Million)
Table 7. Global Cyclopentolate Market Share in Value by Type (2024-2024)
Table 8. Global Cyclopentolate Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Cyclopentolate Sales by Type (2024-2034) & (K Units)
Table 10. Global Cyclopentolate Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Cyclopentolate Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Cyclopentolate Sales Market Share in Value by Type (2024-2034)
Table 13. Global Cyclopentolate Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Cyclopentolate Sales by Type (2024-2024) & (K Units)
Table 15. North America Cyclopentolate Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Cyclopentolate Sales (K Units) by Type (2024-2024)
Table 17. Europe Cyclopentolate Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Cyclopentolate Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Cyclopentolate Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Cyclopentolate Sales (K Units) by Type (2024-2024)
Table 21. Latin America Cyclopentolate Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Cyclopentolate Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Cyclopentolate Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Cyclopentolate Sales by Company (2024-2024) & (K Units)
Table 25. Global Cyclopentolate Sales Share by Company (2024-2024)
Table 26. Global Cyclopentolate Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Cyclopentolate Revenue Share by Company (2024-2024)
Table 28. Global Market Cyclopentolate Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Cyclopentolate Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Cyclopentolate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cyclopentolate as of 2022)
Table 32. Date of Key Manufacturers Enter into Cyclopentolate Market
Table 33. Key Manufacturers Cyclopentolate Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Cyclopentolate Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Cyclopentolate Sales by Region (2024-2024) & (K Units)
Table 37. Global Cyclopentolate Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Cyclopentolate Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Cyclopentolate Sales Market Share in Value by Region (2024-2024)
Table 40. Global Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Cyclopentolate Sales by Region (2024-2034) & (K Units)
Table 42. Global Cyclopentolate Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Cyclopentolate Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Cyclopentolate Sales Market Share in Value by Region (2024-2034)
Table 45. Global Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Cyclopentolate Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Cyclopentolate Sales by Application (2024-2024) & (K Units)
Table 48. Global Cyclopentolate Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Cyclopentolate Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Cyclopentolate Sales Market Share in Value by Application (2024-2024)
Table 51. Global Cyclopentolate Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Cyclopentolate Sales by Application (2024-2034) & (K Units)
Table 53. Global Cyclopentolate Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Cyclopentolate Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Cyclopentolate Sales Market Share in Value by Application (2024-2034)
Table 56. Global Cyclopentolate Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Cyclopentolate Sales by Application (2024-2024) (K Units)
Table 58. North America Cyclopentolate Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Cyclopentolate Sales by Application (2024-2024) (K Units)
Table 60. Europe Cyclopentolate Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Cyclopentolate Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Cyclopentolate Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Cyclopentolate Sales by Application (2024-2024) (K Units)
Table 64. Latin America Cyclopentolate Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Cyclopentolate Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Cyclopentolate Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Cyclopentolate Sales by Country (2024-2024) & (K Units)
Table 68. North America Cyclopentolate Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Cyclopentolate Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Cyclopentolate Sales Market Share in Value by Country (2024-2024)
Table 71. North America Cyclopentolate Sales by Country (2024-2034) & (K Units)
Table 72. North America Cyclopentolate Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Cyclopentolate Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Cyclopentolate Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Cyclopentolate Sales by Country (2024-2024) & (K Units)
Table 76. Europe Cyclopentolate Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Cyclopentolate Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Cyclopentolate Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Cyclopentolate Sales by Country (2024-2034) & (K Units)
Table 80. Europe Cyclopentolate Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Cyclopentolate Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Cyclopentolate Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Cyclopentolate Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Cyclopentolate Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Cyclopentolate Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Cyclopentolate Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Cyclopentolate Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Cyclopentolate Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Cyclopentolate Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Cyclopentolate Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Cyclopentolate Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Cyclopentolate Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Cyclopentolate Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Cyclopentolate Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Cyclopentolate Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Cyclopentolate Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Cyclopentolate Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Cyclopentolate Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Cyclopentolate Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Cyclopentolate Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Cyclopentolate Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Cyclopentolate Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Cyclopentolate Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Cyclopentolate Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Cyclopentolate Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Cyclopentolate Sales Market Share in Value by Country (2024-2034)
Table 107. Alcon Company Information
Table 108. Alcon Introduction and Business Overview
Table 109. Alcon Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Alcon Cyclopentolate Product
Table 111. Alcon Recent Development
Table 112. Novartis Company Information
Table 113. Novartis Introduction and Business Overview
Table 114. Novartis Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Novartis Cyclopentolate Product
Table 116. Novartis Recent Development
Table 117. Laboratório Edol Company Information
Table 118. Laboratório Edol Introduction and Business Overview
Table 119. Laboratório Edol Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Laboratório Edol Cyclopentolate Product
Table 121. Laboratório Edol Recent Development
Table 122. Cadila Healthcare Company Information
Table 123. Cadila Healthcare Introduction and Business Overview
Table 124. Cadila Healthcare Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Cadila Healthcare Cyclopentolate Product
Table 126. Cadila Healthcare Recent Development
Table 127. FDC Company Information
Table 128. FDC Introduction and Business Overview
Table 129. FDC Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. FDC Cyclopentolate Product
Table 131. FDC Recent Development
Table 132. Dr. Gerhard Mann Company Information
Table 133. Dr. Gerhard Mann Introduction and Business Overview
Table 134. Dr. Gerhard Mann Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Dr. Gerhard Mann Cyclopentolate Product
Table 136. Dr. Gerhard Mann Recent Development
Table 137. Abdi Ibrahim Company Information
Table 138. Abdi Ibrahim Introduction and Business Overview
Table 139. Abdi Ibrahim Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Abdi Ibrahim Cyclopentolate Product
Table 141. Abdi Ibrahim Recent Development
Table 142. Laboratorios Sophia Company Information
Table 143. Laboratorios Sophia Introduction and Business Overview
Table 144. Laboratorios Sophia Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Laboratorios Sophia Cyclopentolate Product
Table 146. Laboratorios Sophia Recent Development
Table 147. Bausch and Lomb Company Information
Table 148. Bausch and Lomb Introduction and Business Overview
Table 149. Bausch and Lomb Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Bausch and Lomb Cyclopentolate Product
Table 151. Bausch and Lomb Recent Development
Table 152. Santen Company Information
Table 153. Santen Introduction and Business Overview
Table 154. Santen Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Santen Cyclopentolate Product
Table 156. Santen Recent Development
Table 157. Riemser Arzneimittel Company Information
Table 158. Riemser Arzneimittel Introduction and Business Overview
Table 159. Riemser Arzneimittel Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Riemser Arzneimittel Cyclopentolate Product
Table 161. Riemser Arzneimittel Recent Development
Table 162. Teva Company Information
Table 163. Teva Introduction and Business Overview
Table 164. Teva Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Teva Cyclopentolate Product
Table 166. Teva Recent Development
Table 167. Akorn Company Information
Table 168. Akorn Introduction and Business Overview
Table 169. Akorn Cyclopentolate Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Akorn Cyclopentolate Product
Table 171. Akorn Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Cyclopentolate Market Trends
Table 175. Cyclopentolate Market Drivers
Table 176. Cyclopentolate Market Challenges
Table 177. Cyclopentolate Market Restraints
Table 178. Cyclopentolate Distributors List
Table 179. Cyclopentolate Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyclopentolate Product Picture
Figure 2. Global Cyclopentolate Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Cyclopentolate Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Cyclopentolate Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Patent
Figure 6. Global Patent Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Generic
Figure 8. Global Generic Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Cyclopentolate Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Cyclopentolate Sales Market Share by Type in 2022 & 2034
Figure 11. North America Cyclopentolate Sales Market Share in Volume by Type in 2022
Figure 12. North America Cyclopentolate Sales Market Share in Value by Type in 2022
Figure 13. Europe Cyclopentolate Sales Market Share in Volume by Type in 2022
Figure 14. Europe Cyclopentolate Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Cyclopentolate Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Cyclopentolate Sales Market Share in Value by Type in 2022
Figure 17. Latin America Cyclopentolate Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Cyclopentolate Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Cyclopentolate Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Cyclopentolate Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Cyclopentolate Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Cyclopentolate Revenue in 2022
Figure 23. Cyclopentolate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Mydriatic Agent
Figure 25. Global Mydriatic Agent Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Muscarinic Receptor Antagonist
Figure 27. Global Muscarinic Receptor Antagonist Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Global Cyclopentolate Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Cyclopentolate Sales Market Share by Application in 2022 & 2034
Figure 30. North America Cyclopentolate Sales Market Share in Volume by Application in 2022
Figure 31. North America Cyclopentolate Sales Market Share in Value by Application in 2022
Figure 32. Europe Cyclopentolate Sales Market Share in Volume by Application in 2022
Figure 33. Europe Cyclopentolate Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Cyclopentolate Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Cyclopentolate Sales Market Share in Value by Application in 2022
Figure 36. Latin America Cyclopentolate Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Cyclopentolate Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Cyclopentolate Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Cyclopentolate Manufacturing Cost Structure
Figure 41. Cyclopentolate Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed